Clinical Trials Browser

Phase 1 × OTHER × Metastatic Urothelial Cell Cancer × Clear all

NCT03502681 2022-07-01

A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients

Phase 1 Terminated

6 enrolled 12 charts

Metastatic Urothelial Cell Cancer